Timely identification of human papillomavirus (HPV) infection
is
crucial for the prevention of cervical cancer. Current HPV detection
methods mainly rely on polymerase chain reaction (PCR), which often
requires bulky equipment and a long assay time. In this work, we report
a heating-membrane-assisted multiplexed microfluidics platform that
couples recombinase polymerase amplification (RPA) and CRISPR technology
(termed M3-CRISPR) for fast and low-cost detection of multiple HPV
subtypes. The heating membrane can provide convenient temperature
control for the on-chip RPA and CRISPR assays. This stand-alone system
allows simultaneous detection of HPV16 and HPV18 with high specificity
and detection sensitivity (0.5 nM and 1 × 10–18 M for unamplified and amplified plasmids, respectively) in 30 min
with a fluorescence-based readout. Furthermore, we introduced an optimized
lateral flow dipstick (LFD) into the portable system to allow visualized
detection of HPV DNA. The LFD-based readout also reached a detection
sensitivity of 1 × 10–18 M for amplified plasmids
and realized successful detection of HPV subtypes in the clinical
samples. Finally, we established an automatic microfluidic system
that enables the sample-in-answer-out detection of HPV subtypes. We
believe that this fast, convenient, and affordable molecular diagnostic
platform can serve as a useful tool in point-of-care testing of HPV
or other pathogens.